Symbotic reported strong Q1 results with revenues and adjusted EBITDA coming in above the Company’s previous guidance and consensus expectations.
Symbotic Sales Continue To Inflect, But Patient Investors Will Likely Have A More Attractive Entry Point - HOLD
Symbotic Sales Continue To Inflect, But…
Symbotic Sales Continue To Inflect, But Patient Investors Will Likely Have A More Attractive Entry Point - HOLD
Symbotic reported strong Q1 results with revenues and adjusted EBITDA coming in above the Company’s previous guidance and consensus expectations.